EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Role and Mechanism of Endothelial Progenitor Cell–Derived Extracellular Vesicles in Vascular Repair of Ischemic Heart Disease

Qiling Han, Xinmei Wang, Houjin Zhao

Journal of Cardiovascular Translational Research · 2026

DOI: 10.1007/s12265-026-10822-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Translational Research, 2026. Verfasst von Qiling Han und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science and Engineering, Shenyang University, Shenyang, Liaoning, 110003, China. Hauptthemen laut MEDLINE: Endothelial Progenitor Cells, Extracellular Vesicles, Myocardial Ischemia, Neovascularization, Physiologic. Die Arbeit nennt 198 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemic heart disease (IHD) remains a leading global cause of death, sustained by microvascular dysfunction and defective endogenous repair despite revascularization. Endothelial progenitor cells (EPCs) were initially proposed as regenerative mediators, but direct cell therapy is constrained by poor engraftment, phenotypic heterogeneity, and safety concerns. Accumulating evidence establishes EPC-derived extracellular vesicles (EPC-EVs) as the principal effectors of vascular repair. These vesicles deliver bioactive cargo—including miR-126, miR-210, lncRNAs, and proteins that activate VEGF/PI3K/AKT/eNOS signaling in endothelial cells, promote angiogenesis and endothelial survival, attenuate apoptosis and ferroptosis, and induce reparative M2 macrophage polarization. Compared with cell therapy, EPC-EVs offer superior stability, lower immunogenicity, and manufacturing control as a cell-free platform. Translational challenges persist, including inconsistent EPC definitions, isolation variability, absence of validated potency assays linked to cardiovascular endpoints, and limited long-term safety data. Engineering strategies such as hypoxic preconditioning and targeted delivery may facilitate clinical translation of EPC-EV therapy for IHD. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelial Progenitor CellsExtracellular VesiclesMyocardial IschemiaNeovascularization, PhysiologicRegenerationAngiogenesisHumansAnimalsSignal Transduction

Stichwörter der Autor:innen

AngiogenesisEndothelial Progenitor CellsExtracellular VesiclesIschemic Heart DiseaseVascular Repair

Autor:innen und Institutionen

  • College of Life Science and Engineering, Shenyang University, Shenyang, Liaoning, 110003, China.
  • College of Life Science and Engineering, Shenyang University, Shenyang, Liaoning, 110003, China. xinmwang@syu.edu.cn.

Zitieren

APA

Han, Q., Wang, X., & Zhao, H. (2026). The Role and Mechanism of Endothelial Progenitor Cell–Derived Extracellular Vesicles in Vascular Repair of Ischemic Heart Disease. Journal of Cardiovascular Translational Research. https://doi.org/10.1007/s12265-026-10822-3

Vancouver

Han Q, Wang X, Zhao H. The Role and Mechanism of Endothelial Progenitor Cell–Derived Extracellular Vesicles in Vascular Repair of Ischemic Heart Disease. Journal of Cardiovascular Translational Research. 2026. doi:10.1007/s12265-026-10822-3

BibTeX
@article{Han2026,
  author = {Han, Qiling and Wang, Xinmei and Zhao, Houjin},
  title = {The Role and Mechanism of Endothelial Progenitor Cell–Derived Extracellular Vesicles in Vascular Repair of Ischemic Heart Disease},
  journal = {Journal of Cardiovascular Translational Research},
  year = {2026},
  doi = {10.1007/s12265-026-10822-3}
}
Kostenlos starten →